EP1362089B1 - Reduction of malodour from laundry - Google Patents

Reduction of malodour from laundry Download PDF

Info

Publication number
EP1362089B1
EP1362089B1 EP02711783A EP02711783A EP1362089B1 EP 1362089 B1 EP1362089 B1 EP 1362089B1 EP 02711783 A EP02711783 A EP 02711783A EP 02711783 A EP02711783 A EP 02711783A EP 1362089 B1 EP1362089 B1 EP 1362089B1
Authority
EP
European Patent Office
Prior art keywords
lysostaphin
enzyme
laundry
detergent
malodor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP02711783A
Other languages
German (de)
French (fr)
Other versions
EP1362089A1 (en
Inventor
Charlotte Johansen
Signe Munk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Publication of EP1362089A1 publication Critical patent/EP1362089A1/en
Application granted granted Critical
Publication of EP1362089B1 publication Critical patent/EP1362089B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0068Deodorant compositions
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38636Preparations containing enzymes, e.g. protease or amylase containing enzymes other than protease, amylase, lipase, cellulase, oxidase or reductase
    • C11D2111/12

Definitions

  • the invention relates to enzymatic reduction of malodor from laundry.
  • WO 90/09739 discloses compositions including lysostaphin and nisin, which are used for treating bacterial infections.
  • WO 91/10723 discloses a bacteriolytic enzyme from Nocardiopsis dassonvillei and it's use in e.g. detergent compositions.
  • the invention provides a method comprising contacting laundry with an enzyme having lysostaphin activity.
  • composition comprising a surfactant and an enzyme having lysostaphin activity and one or more other enzymes selected from protease, lipase, cutinase, amylase, carbohy-drase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, laccase, and peroxidase.
  • Lysostaphin is a glycyl-glycine endopeptidase from the enzyme class E.C. 3.4.24.75. It hydrolyses the -Gly-Gly- bond in the polyglycine inter-peptide link joining staphylococcal cell wall peptidoglycans. Lysostaphin is commercially available from several suppliers, such as from Sigma-Aldrich, Inc.
  • An enzyme having lysostaphin activity may be a natural or synthetic variant of lysostaphin, wherein amino acid substitutions or deletions have been introduced. It may also be an amino acid fragment with lysostaphin activity, which is optionally fused to one or more other proteins.
  • lysostaphin activity will reduce the turbidity (absorbance at 620 nm) of a suspension of Staphylococcus aureus (ATCC 6538) cells by 50%, when the initial absorbance is approximately 0.250, after 10 minutes at pH 7.5 and 37 degrees celcius.
  • the malodor of the method of the invention thus comprises all body odors present in laundry originating from contact with the human skin.
  • the malodor may be axillary odors, such as the smell of sweat.
  • the malodor may originate from activity of Staphylococcus species (such as S . aureus, S. epidermis, S. intermedius, S. saprophyticus and S. hyicus).
  • Staphylococcus species such as S . aureus, S. epidermis, S. intermedius, S. saprophyticus and S. hyicus.
  • the malodor originates from fabrics which have been in contact with the axilla.
  • the laundry of the method of the invention comprises all kinds of textile items or fabrics suitable for being used as clothes or for personal use in other ways comprising contact with the human skin.
  • the "Malodor index (48 hours)" may be reduced by at least 10% (preferably 20%, more preferably 30%, most preferably 40%, and in particular 50%) compared to laundry which has not been contacted with an enzyme having lysostaphin activity.
  • the method of the invention may also result in killing or inhibiting growth of microbial cells in laundry.
  • the microbial cells are bacteria, such as Staphylococcus species.
  • the method of the invention may result in a reduction in the number of living microbial cells of at least 25%, preferably at least 50%, more preferably at least 90%, and most preferably at least 99%.
  • microbial cells denotes bacterial cells (such as Staphylococcus species), fungal cells or algae, and the term “microorganism” denotes a fungus (including yeasts) or a bacterium
  • the present invention covers use of an enzyme for reducing malodor from laundry items.
  • the enzyme may have lysostaphin activity.
  • the invention may also be used for reducing the number of living bacteria in laundry; for reducing allergens in laundry; or for sterilizing laundry.
  • Lysostaphin may be added to and thus become a component of a detergent composition.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising lysostaphin.
  • the detergent additive as well as the detergent composition comprises one or more other enzymes selected from protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, laccase and peroxidase.
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include AlcalaseTM, SavinaseTM, PrimaseTM, EverlaseTM, EsperaseTM, and KannaseTM (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, and FN3TM (Genencor International Inc.).
  • Lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa ( T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H . insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P . pseudoalcaligenes (EP 218 272), P . cepacia (EP 331 376), P . stutzeri (GB 1,372,034), P .
  • lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Preferred commercially available lipase enzymes include LipolaseTM, Lipolase UltraTM and LipoprimeTM(Novozymes A/S).
  • Amylases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B . licheniformis, described in more detail in GB 1,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
  • amylases are DuramylTM, TermamylTM, FungamylTM and BANTM (Novozymes A/S), RapidaseTM and PurastarTM (Genencor International Inc.).
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691,178, US 5,776,757 and WO 89/09259.
  • cellulases are the alkaline or neutral cellulases having colour care benefits.
  • Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
  • cellulases include CelluzymeTM, and CarezymeTM (Novozymes A/S), ClazinaseTM, and Puradax HATM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C . cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
  • the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a detergent additive of the invention i.e. a separate additive or a combined additive, can be formulated e.g. as a granulate, a liquid, a slurry, etc.
  • Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art.
  • waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591.
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • the detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
  • a liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or nonaqueous.
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1 % to 60% by weight.
  • the detergent When included therein the detergent will usually contain from about 1 % to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides").
  • a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • glucamides N-acyl N-alkyl derivatives of glucosamine
  • the detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
  • a bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • a polyol such as propylene glycol or glycerol
  • a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anticorrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anticorrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • any enzyme in particular lysostaphin, may be added in an amount corresponding to 0.01-100 mg of enzyme protein per liter of wash liquor, preferably 0.05-10 mg of enzyme protein per liter of wash liquor, more preferably 0.1-5 mg of enzyme protein per liter of wash liquor, and most preferably 0.1-1 mg of enzyme protein per liter of wash liquor.
  • Lysostaphin may additionally be incorporated in the detergent formulations disclosed in WO 97/07202.
  • the chemicals used in the following examples were commercial products of at least reagent grade.
  • the Malthus Flexi M2060 instrument is available from Malthus Instruments Limited, England.
  • TLB Tryptone Soya Broth
  • lysostaphin is tested in a one-cycle washing trial carried out in a thermostated Terg-O-tometer (available from United States Testing Co, 1415 Park Ave, Hoboken NJ07030).
  • Swatches of 100% polyester or 100% cotton (10 x 14 cm, previously cleaned by solvent extraction - hexane for polyester, chloroform for cotton - using a Soxhlet) are soiled by applying human male axillary sweat and sebum from the armpits and upper body of male runners after extensive exercise.
  • Two swatches (10 x 14 cm) are used for each male - one swatch is made of 100% polyester and one is made of 100% cotton.
  • the left armpit and left part of the upper body is wiped with one swatch, and the right armpit and right part of the upper body is wiped with the other swatch after exercising. This procedure is performed twice before washing. Prior to the washing, each swatch is cut into 12 equally sized pieces and distributed between four Terg-O-tometer wash beakers. Cotton and polyester textiles are kept apart.
  • Washing is done in Terg-O-tometer using phosphate buffer (0.05 M, pH 7.5). Temperature: 32°C Lysostaphin dose: 5 mg/L (Sigma L4402) Wash time: 12 minutes Wash liquid: 1000 mL per wash beaker Rinsing: 15 minutes in running tap water
  • Staphylococcus aureus was grown overnight (TSB; Tryptone Soya Broth) and inoculated to approximately 10 3 Colony forming units/ml (CFU/ml) in diluted TSB (1:1).
  • TSB Tryptone Soya Broth
  • CFU/ml Colony forming units/ml
  • Sterile cotton swatches were inoculated overnight in the diluted TSB allowing S.aureus to grow on the textile.
  • the swatches were rinsed in sterile water for 30 seconds and dried in sterile air for 30 minutes. Swatches were washed in a beaker with stirring at 32°C for 20 minutes in either phosphate buffer (0.05 M, pH 7.5) or in a liquid U.S.
  • Direct Malthus measurements were used when enumerating total survival cells.
  • the cell metabolism was determined by conductance measurements in the growth substrate. The swatches were after enzyme treatment transferred to the Malthus cell. As cells attached to the textile are growing, the cell metabolism will change the conductance in the growth medium. When the conductance change is measurable by the Malthus, a detection time (dt) will be recorded. The dt's were converted to colony counts by use of a calibration curve relating CFU/swatch to dt.
  • Lysostaphin resulted in a reduction of the microbial cell number of approximately 10 1 to 10 2 CFU/swatch.
  • a reduction in cell number was also determined after lysostaphin treatment in detergent, however, the determination of the exact cell number was not possible by using the Malthus. But a delay in outgrowth of the microorganism was observed visually from the swatches washed in detergent with lysostaphin, this delay corresponds to a lower cell number on the swatches compared to the swatches washed without lysostaphin.

Abstract

We have found that an enzyme having lysostaphin activity is capable of reducing malodor from laundry. Accordingly, there is provided a method comprising contacting laundry with an enzyme having lysostaphin activity; and a composition comprising a surfactant and an enzyme having lysostaphin activity.

Description

    FIELD OF THE INVENTION
  • The invention relates to enzymatic reduction of malodor from laundry.
  • BACKGROUND
  • Clothes that have been used for e.g. sports activities or in other ways have been exposed to sweat from the wearer during use are often difficult to clean in terms of the smell of sweat and other body odors (malodor), when subjected to wash in a laundry machine.
  • WO 90/09739 discloses compositions including lysostaphin and nisin, which are used for treating bacterial infections.
  • WO 91/10723 discloses a bacteriolytic enzyme from Nocardiopsis dassonvillei and it's use in e.g. detergent compositions.
  • SUMMARY OF THE INVENTION
  • We have found that an enzyme having lysostaphin activity is capable of reducing malodor from laundry. Accordingly, the invention provides a method comprising contacting laundry with an enzyme having lysostaphin activity.
  • In a second aspect, there is provided a composition comprising a surfactant and an enzyme having lysostaphin activity and one or more other enzymes selected from protease, lipase, cutinase, amylase, carbohy-drase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, laccase, and peroxidase.
  • DETAILED DESCRIPTION Lysostaphin
  • The enzyme Lysostaphin is a glycyl-glycine endopeptidase from the enzyme class E.C. 3.4.24.75. It hydrolyses the -Gly-Gly- bond in the polyglycine inter-peptide link joining staphylococcal cell wall peptidoglycans. Lysostaphin is commercially available from several suppliers, such as from Sigma-Aldrich, Inc.
  • An enzyme having lysostaphin activity may be a natural or synthetic variant of lysostaphin, wherein amino acid substitutions or deletions have been introduced. It may also be an amino acid fragment with lysostaphin activity, which is optionally fused to one or more other proteins.
  • Lysostaphin Activity
  • One unit of lysostaphin activity will reduce the turbidity (absorbance at 620 nm) of a suspension of Staphylococcus aureus (ATCC 6538) cells by 50%, when the initial absorbance is approximately 0.250, after 10 minutes at pH 7.5 and 37 degrees celcius.
  • Malodor
  • During wear, fabrics are contaminated with microorganisms from the human skin together with sebaceous lipids, sweat and dead skin cells serving as microbial substrates. Particularly at mild wash conditions these microorganisms survive laundering. A consequence of microorganisms surviving household laundering is malodor generation in the fabrics. We have now found that these microorganisms are mainly Staphylococcus species.
  • The malodor of the method of the invention thus comprises all body odors present in laundry originating from contact with the human skin. In an embodiment the malodor may be axillary odors, such as the smell of sweat.
  • In another embodiment, the malodor may originate from activity of Staphylococcus species (such as S. aureus, S. epidermis, S. intermedius, S. saprophyticus and S. hyicus).
  • In yet another embodiment the malodor originates from fabrics which have been in contact with the axilla.
  • Evaluation of Malodor
  • Wet laundry swatches are placed in tinted 200 ml glasses with snap lids. A trained sensory panel (10 persons) evaluates the odor by sniffing the headspace over the wet items and indicating the total odor intensity. The odor intensity is indicated on a scale from 0 to 15 where 0 equals 'no malodor' and 15 equals 'very strong malodor'. All evaluations are performed twice (double determinations). The swatches are evaluated after approximately 24 hours and after 48 hours (swatches are kept in the glasses at all times). An average of all 20 evaluations (10 persons each evaluate twice) is calculated after both 24 hours and 48 hours. These average values are referred to as "Malodor index (24 hours)" and "Malodor index (48 hours)".
  • Laundry
  • The laundry of the method of the invention comprises all kinds of textile items or fabrics suitable for being used as clothes or for personal use in other ways comprising contact with the human skin.
  • Methods and Uses
  • By contacting laundry with an enzyme having lysostaphin activity, as defined in the method of the invention, the "Malodor index (48 hours)", as defined above, may be reduced by at least 10% (preferably 20%, more preferably 30%, most preferably 40%, and in particular 50%) compared to laundry which has not been contacted with an enzyme having lysostaphin activity.
  • The method of the invention may also result in killing or inhibiting growth of microbial cells in laundry. In an embodiment the microbial cells are bacteria, such as Staphylococcus species. In another embodiment, the method of the invention may result in a reduction in the number of living microbial cells of at least 25%, preferably at least 50%, more preferably at least 90%, and most preferably at least 99%.
  • In the context of the present invention the term "inhibiting growth of microbial cells" is intended to mean that the cells are in the non-growing state, i.e., that they are not propagating. The term "microbial cells" denotes bacterial cells (such as Staphylococcus species), fungal cells or algae, and the term "microorganism" denotes a fungus (including yeasts) or a bacterium
  • The present invention covers use of an enzyme for reducing malodor from laundry items. In an embodiment, the enzyme may have lysostaphin activity. The invention may also be used for reducing the number of living bacteria in laundry; for reducing allergens in laundry; or for sterilizing laundry.
  • Detergent composition
  • Lysostaphin may be added to and thus become a component of a detergent composition.
  • The detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general household hard surface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • In a specific aspect, the invention provides a detergent additive comprising lysostaphin. The detergent additive as well as the detergent composition comprises one or more other enzymes selected from protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, laccase and peroxidase.
  • In general the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • Proteases: Suitable proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included. The protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease. Examples of alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 and subtilisin 168 (described in WO 89/06279). Examples of trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • Examples of useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101, 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include Alcalase™, Savinase™, Primase™, Everlase™, Esperase™, and Kannase™ (Novozymes A/S), Maxatase™, Maxacal™, Maxapem™, Properase™, Purafect™, Purafect OxP™, FN2™, and FN3™ (Genencor International Inc.).
  • Lipases: Suitable lipases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P.pseudoalcaligenes (EP 218 272), P. cepacia (EP 331 376), P. stutzeri (GB 1,372,034), P. fluorescens, Pseudomonas sp. strain SD 705 (WO 95/06720 and WO 96/27002), P. wisconsinensis (WO 96/12012), a Bacillus lipase, e.g. from B. subtilis (Dartois et al. (1993), Biochemica et Biophysica Acta, 1131, 253-360), B. stearothermophilus (JP 64/744992) or B. pumilus (WO 91/16422).
  • Other examples are lipase variants such as those described in WO 92/05249, WO 94/01541, EP 407 225, EP 260 105, WO 95/35381, WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Preferred commercially available lipase enzymes include Lipolase™, Lipolase Ultra™ and Lipoprime™(Novozymes A/S).
  • Amylases: Suitable amylases (α and/or β) include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Amylases include, for example, α-amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1,296,839.
  • Examples of useful amylases are the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181, 188, 190, 197, 202, 208, 209, 243, 264, 304, 305, 391, 408, and 444.
  • Commercially available amylases are Duramyl™, Termamyl™, Fungamyl™ and BAN™ (Novozymes A/S), Rapidase™ and Purastar™ (Genencor International Inc.).
  • Cellulases: Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691,178, US 5,776,757 and WO 89/09259.
  • Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits. Examples of such cellulases are cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940. Other examples are cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471, WO 98/12307 and PCT/DK98/00299.
  • Commercially available cellulases include Celluzyme™, and Carezyme™ (Novozymes A/S), Clazinase™, and Puradax HA™ (Genencor International Inc.), and KAC-500(B)™ (Kao Corporation).
  • Peroxidases/Oxidases: Suitable peroxidases/oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257.
  • The detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes. A detergent additive of the invention, i.e. a separate additive or a combined additive, can be formulated e.g. as a granulate, a liquid, a slurry, etc. Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming coating materials suitable for application by fluid bed techniques are given in GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • The detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid. A liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or nonaqueous.
  • The detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic. The surfactants are typically present at a level of from 0.1 % to 60% by weight.
  • When included therein the detergent will usually contain from about 1 % to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, alkyl sulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine ("glucamides").
  • The detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylenediaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • The detergent may comprise one or more polymers. Examples are carboxymethylcellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinylpyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as polyacrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • The detergent may contain a bleaching system which may comprise a H2O2 source such as perborate or percarbonate which may be combined with a peracid-forming bleach activator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate. Alternatively, the bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • The enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • The detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anticorrosion agents, soil-suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • It is at present contemplated that in the detergent compositions any enzyme, in particular lysostaphin, may be added in an amount corresponding to 0.01-100 mg of enzyme protein per liter of wash liquor, preferably 0.05-10 mg of enzyme protein per liter of wash liquor, more preferably 0.1-5 mg of enzyme protein per liter of wash liquor, and most preferably 0.1-1 mg of enzyme protein per liter of wash liquor.
  • Lysostaphin may additionally be incorporated in the detergent formulations disclosed in WO 97/07202.
  • The present invention is further illustrated in the following examples, which are not in any way intended to limit the scope of the invention as claimed.
  • EXAMPLES
  • The chemicals used in the following examples were commercial products of at least reagent grade.
  • The Malthus Flexi M2060 instrument is available from Malthus Instruments Limited, England.
  • Tryptone Soya Broth (TSB) is available from Oxoid, England.
    CFU: Colony Forming Units.
  • EXAMPLE 1 Evaluation of odour in swatches soiled with human axillary sweat and sebum
  • The odour reducing effect of lysostaphin is tested in a one-cycle washing trial carried out in a thermostated Terg-O-tometer (available from United States Testing Co, 1415 Park Ave, Hoboken NJ07030).
  • Experimental conditions: Soiling
  • Swatches of 100% polyester or 100% cotton (10 x 14 cm, previously cleaned by solvent extraction - hexane for polyester, chloroform for cotton - using a Soxhlet) are soiled by applying human male axillary sweat and sebum from the armpits and upper body of male runners after extensive exercise. Two swatches (10 x 14 cm) are used for each male - one swatch is made of 100% polyester and one is made of 100% cotton. The left armpit and left part of the upper body is wiped with one swatch, and the right armpit and right part of the upper body is wiped with the other swatch after exercising. This procedure is performed twice before washing. Prior to the washing, each swatch is cut into 12 equally sized pieces and distributed between four Terg-O-tometer wash beakers. Cotton and polyester textiles are kept apart.
  • Washing
  • Washing is done in Terg-O-tometer using phosphate buffer (0.05 M, pH 7.5).
    Temperature: 32°C
    Lysostaphin dose: 5 mg/L (Sigma L4402)
    Wash time: 12 minutes
    Wash liquid: 1000 mL per wash beaker
    Rinsing: 15 minutes in running tap water
  • Sensory evaluation
  • After wash the wet swatches are evaluated and "Malodor index (24 hours)" and "Malodor index (48 hours)" are calculated. The results show that a lower "Malodor index (48 hours)" is obtained with the swatches that has been washed with lysostaphin compared to those that has not been washed with lysostaphin.
  • EXAMPLE 2 Removal of bacteria from textile by lysostaphin
  • Staphylococcus aureus (ATCC 6538) was grown overnight (TSB; Tryptone Soya Broth) and inoculated to approximately 103 Colony forming units/ml (CFU/ml) in diluted TSB (1:1). Sterile cotton swatches were inoculated overnight in the diluted TSB allowing S.aureus to grow on the textile. The swatches were rinsed in sterile water for 30 seconds and dried in sterile air for 30 minutes. Swatches were washed in a beaker with stirring at 32°C for 20 minutes in either phosphate buffer (0.05 M, pH 7.5) or in a liquid U.S. detergent of a commercial type (0.75 g/liter) with and without addition of 5 mg/L Lysostaphin (Sigma L4402). Three swatches were washed in each beaker. After wash all swatches were rinsed in sterile water for 10 minutes and dried in sterile air. The number of living S. aureus on the swatches was determined by incubation of the swatches in Malthus tubes with CASO medium (Merck 1.05459). The bactericidal activity was determined by incubation in Malthus. The detection times (dt) measured by the Malthus instrument were converted to CFU/swatch by a calibration curve (Johansen et al. 1999, Methods in Enzymology, vol 310, p. 353-360). Direct Malthus measurements were used when enumerating total survival cells. By the direct measurements, the cell metabolism was determined by conductance measurements in the growth substrate. The swatches were after enzyme treatment transferred to the Malthus cell. As cells attached to the textile are growing, the cell metabolism will change the conductance in the growth medium. When the conductance change is measurable by the Malthus, a detection time (dt) will be recorded. The dt's were converted to colony counts by use of a calibration curve relating CFU/swatch to dt.
  • Results:
  • Swatch Beaker Average number of S. aureus on each swatch
    (three swatches washed in each beaker)
    Reference swatches before wash 8.8 x 107 CFU/swatch
    Washed in phosphate buffer 1 2.2 x 107 CFU/swatch
    2 7.3 x 106 CFU/swatch
    Washed in phosphate buffer with 1 4.6 x 106 CFU/swatch
    lysostaphin (5 mg/L) 2 1.2 x 105 CFU/swatch
    3 4.8 x 105 CFU/swatch
  • Lysostaphin resulted in a reduction of the microbial cell number of approximately 101 to 102 CFU/swatch. A reduction in cell number was also determined after lysostaphin treatment in detergent, however, the determination of the exact cell number was not possible by using the Malthus. But a delay in outgrowth of the microorganism was observed visually from the swatches washed in detergent with lysostaphin, this delay corresponds to a lower cell number on the swatches compared to the swatches washed without lysostaphin.

Claims (8)

  1. A method comprising contacting laundry with an enzyme having lysostaphin activity.
  2. The method of claim 1, wherein the enzyme is lysostaphin.
  3. The method of claim 1, which is a method for reducing malodor from laundry.
  4. The method of claim 3, wherein the "malodor index (48 hours)" is reduced 10% compared to laundry which has not been contacted with an enzyme having lysostaphin activity.
  5. A composition comprising a surfactant and an enzyme having lysostaphin activity and one or more other enzymes selected from protease, lipase, cutinase, amylase, carbohydrase, cellulase, pectinase, mannanase, arabinase, galactanase, xylanase, oxidase, laccase and peroxidase.
  6. The composition of claim 5, wherein the enzyme is lysostaphin.
  7. Use of an enzyme having lysostaphin activity for reducing malodor from laundry.
  8. Use of lysostaphin for reducing malodor from laundry.
EP02711783A 2001-02-17 2002-02-12 Reduction of malodour from laundry Expired - Lifetime EP1362089B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200100270 2001-02-17
DKPA200100270 2001-02-17
PCT/DK2002/000097 WO2002066591A1 (en) 2001-02-17 2002-02-12 Reduction of malodour from laundry

Publications (2)

Publication Number Publication Date
EP1362089A1 EP1362089A1 (en) 2003-11-19
EP1362089B1 true EP1362089B1 (en) 2007-01-03

Family

ID=8160255

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02711783A Expired - Lifetime EP1362089B1 (en) 2001-02-17 2002-02-12 Reduction of malodour from laundry

Country Status (6)

Country Link
EP (1) EP1362089B1 (en)
JP (1) JP4071632B2 (en)
AT (1) ATE350448T1 (en)
AU (1) AU2002231607B2 (en)
DE (1) DE60217297T2 (en)
WO (1) WO2002066591A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2435773T3 (en) 2005-09-02 2013-12-23 The Procter & Gamble Company Aroma customization for laundry
DE102006008996A1 (en) * 2006-02-23 2007-09-06 Weber, Lothar Ernst Wilhelm Means and methods for purifying the indoor air of pollutants, odors and other interfering constituents
CN105441353B (en) 2006-08-11 2019-01-01 诺维信生物股份有限公司 Bacterial cultures and composition comprising bacterial cultures
AU2012217673B2 (en) 2011-02-15 2017-06-15 Henkel Ag & Co. Kgaa Mitigation of odor in cleaning machines and cleaning processes
WO2019059804A1 (en) 2017-09-25 2019-03-28 Георгий Георгиевич ЧУМБУРИДЗЕ Thermostable composition with antiviral and antibacterial activity and use thereof
EP3741857A4 (en) 2018-01-16 2021-12-22 Kao Corporation Detergent for corneum-derived stains, and method for evaluating ability to degrade corneum-derived stains

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009739A1 (en) * 1989-03-01 1990-09-07 The Public Health Research Institute Of The City Of New York, Inc. Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496363A (en) * 1983-11-21 1985-01-29 Uop Inc. Antimicrobial fabrics
US4810567A (en) * 1985-08-21 1989-03-07 Uop Antimicrobial fabrics utilizing graft copolymers
DE69008194T2 (en) * 1990-01-11 1994-07-28 Novo Nordisk As BACTERIOLYTIC ENZYME FROM A NOCARDIOPSIS STRAIN, ITS PRODUCTION AND USE.
US5762948A (en) * 1995-06-07 1998-06-09 Ambi Inc. Moist bacteriocin disinfectant wipes and methods of using the same
WO1997031999A1 (en) * 1996-02-29 1997-09-04 The Procter & Gamble Company Cleaning compositions comprising endo-dextranase
MX9809587A (en) * 1996-05-15 1999-03-01 Procter & Gamble Detergent compositions comprising a combination of alpha-amylases for malodor stripping
JPH09310092A (en) * 1996-05-22 1997-12-02 Lion Corp Detergent composition for removing fish smell and its employment
US6080391A (en) * 1997-08-14 2000-06-27 Novo Nordisk A/S Reduction of malodour

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009739A1 (en) * 1989-03-01 1990-09-07 The Public Health Research Institute Of The City Of New York, Inc. Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection

Also Published As

Publication number Publication date
EP1362089A1 (en) 2003-11-19
WO2002066591A1 (en) 2002-08-29
ATE350448T1 (en) 2007-01-15
DE60217297D1 (en) 2007-02-15
JP2004527603A (en) 2004-09-09
JP4071632B2 (en) 2008-04-02
DE60217297T2 (en) 2007-10-04
AU2002231607B2 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
Hasan et al. Enzymes used in detergents: lipases
EP2126027B1 (en) Enzyme foam treatment for laundry
CA2275157C (en) A method for enzymatic treatment of biofilm
CN103865682B (en) Stable Enzyme Solutions and Method of Manufacturing
US20020192792A1 (en) Laccase mutants
WO1999057360A1 (en) Enhancers such as n-hydroxyacetanilide
KR19990087601A (en) How to kill or suppress microbial cells
US6228128B1 (en) Antimicrobial activity of laccases
JP2001522784A (en) Antibacterial activity of laccase
CN112969775A (en) Cleaning composition
WO2006131503A2 (en) Detergents with enzymatic builder and bleach systems
AU772299B2 (en) Antimicrobial composition comprising an oxidoreductase and an enhancing agent of the N-hydroxyanilide-type
EP1362089B1 (en) Reduction of malodour from laundry
US6794350B2 (en) Reduction of malodor from laundry
Crutzen et al. Detergent enzymes: a challenge!
AU2002231607A1 (en) Reduction of malodour from laundry
WO2001011969A1 (en) ENZYMATIC METHOD FOR KILLING OR INHIBITING MICROBIAL CELLS AT HIGH pH
WO2001084937A1 (en) Oxidoreductase mediated antimicrobial activity
CN104755615A (en) Improved method for manual dish wash
EP2935549B1 (en) Method for removing fat and/or oil stains
CA2438510C (en) Reduction of malodor from laundry
US20020102246A1 (en) Antimicrobial compositions
US20060142171A1 (en) Novel alkaline protease
US6592867B2 (en) Antimicrobial composition containing an oxidoreductase and an enhancer of the N-hydroxyanilide-type
CN115011418B (en) Liquid composition with stabilized protease activity

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20030917

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

RIN1 Information on inventor provided before grant (corrected)

Inventor name: MUNK, SIGNE

Inventor name: JOHANSEN, CHARLOTTE

17Q First examination report despatched

Effective date: 20020315

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60217297

Country of ref document: DE

Date of ref document: 20070215

Kind code of ref document: P

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070403

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070414

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070604

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20071005

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070404

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070212

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070103

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 15

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 16

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210223

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20210225

Year of fee payment: 20

Ref country code: DE

Payment date: 20210225

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 60217297

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20220211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20220211